Global Active Pharmaceutical Ingredients Market Insights, Forecast to 2025

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs.
This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place.

The global Active Pharmaceutical Ingredients market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Active Pharmaceutical Ingredients market based on company, product type, end user and key regions.

This report studies the global market size of Active Pharmaceutical Ingredients in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Pharmaceutical Ingredients in these regions.
This research report categorizes the global Active Pharmaceutical Ingredients market by top players/brands, region, type and end user. This report also studies the global Active Pharmaceutical Ingredients market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Novartis
Pfizer
Roche
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Abbott Laboratories
Emcure Pharmaceuticals
Ipca Laboratories
Johnson Matthey
Guilin Pharmaceutical
Johnson & Johnson
Lonza Group

Market size by Product
Synthetic
Biotech
Market size by End User
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Active Pharmaceutical Ingredients market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Active Pharmaceutical Ingredients market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Active Pharmaceutical Ingredients companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Active Pharmaceutical Ingredients submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredients are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Pharmaceutical Ingredients market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.